Cited by 2733D Printing in Biomedical ResearchMicrofluidic and Capillary Electrophoresis ApplicationsTissue Engineering and Regenerative Medicine

Personalised organs-on-chips: functional testing for precision medicine

Open access
van den Berg, Albert, Mummery, Christine L., Passier, Robert, van der Meer, Andries D.·2019·Lab on a Chip

Abstract

Organs-on-chips are microfluidic systems with controlled, dynamic microenvironments in which cultured cells exhibit functions that emulate organ-level physiology. They can in principle be 'personalised' to reflect individual physiology, for example by including blood samples, primary human tissue, and cells derived from induced pluripotent stem cell-derived cells, as well as by tuning key physico-chemical parameters of the cell culture microenvironment based on personal health data. The personalised nature of such systems, combined with physiologically relevant read-outs, provides new opportunities for person-specific assessment of drug efficacy and safety, as well as personalised strategies for disease prevention and treatment; together, this is known as 'precision medicine'. There are multiple reports of how to personalise organs-on-chips, with examples including airway-on-a-chip systems containing primary patient alveolar epithelial cells, vessels-on-chips with shapes based on personal biomedical imaging data and lung-on-a-chip systems that can be exposed to various regimes of cigarette smoking. In addition, multi-organ chip systems even allow the systematic and dynamic integration of more complex combinations of personalised cell culture parameters. Current personalised organs-on-chips have not yet been used for precision medicine as such. The major challenges that affect the implementation of personalised organs-on-chips in precision medicine are related to obtaining access to personal samples and corresponding health data, as well as to obtaining data on patient outcomes that can confirm the predictive value of personalised organs-on-chips. We argue here that involving all biomedical stakeholders from clinicians and patients to pharmaceutical companies will be integral to transition personalised organs-on-chips to precision medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/c8lc00827b

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tumor-on-chip models can recreate human tumor microenvironments.

    “Tumor-on-chip models based on these organ-on-chip systems can recreate human tumor microenvironments and now hold great promise as a new resource for cost-effective and higher-throughput screening of anticancer drugs [13,14,15,16,17] and powerful enablers of precision medicine [18].”

    From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [18]

    The Introduction says organs-on-chips recreate aspects of human tissue microenvironments and gives an example involving metastatic tumor cells in perfused vessels. It does not establish that tumor-on-chip models recreate the human tumor microenvironment as a whole. In the citing sentence, this source is cited for the separate point about precision medicine, which the paper discusses as a potential application. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Tumor-on-chip models are powerful enablers of precision medicine.

    “Tumor-on-chip models based on these organ-on-chip systems can recreate human tumor microenvironments and now hold great promise as a new resource for cost-effective and higher-throughput screening of anticancer drugs [13,14,15,16,17] and powerful enablers of precision medicine [18].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van den Berg, A., Mummery, C. L., Passier, R., & van der Meer, A. D.
Affiliations
  • BIOS/Lab on a Chip
  • Leiden University Medical Center (NL)
  • University of Twente (NL)
  • Applied Stem Cell Technologies
Venue
Lab on a Chip
Published
2019
Volume
19
Issue
2
Pages
198-205
ISSN
  • 1473-0189 (ISSN-L)
  • 1473-0197
OpenAlex
W2902585499
Cited by
270
References
52
Citations by year
2026: 20 · 2025: 28 · 2024: 36 · 2023: 30 · 2022: 44 · 2021: 57 · 2020: 40 · 2019: 15
FWCI
2.28
Type
journal article
Language
en
Open access
Locations
  • Lab on a Chip (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Twente Research Information (publishedVersion, cc-by)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
  • Leiden Repository (Leiden University) (submittedVersion)
  • University of Twente Research Information (submittedVersion, cc-by)
Funders
  • Dutch National Science Foundation (Gravitation Grant ‘NOCI’ Program, 024.003.001)
  • H2020 European Research Council (VESCEL, 669768)
  • FP7 Ideas: European Research Council (STEMCARDIOVASC, 323182)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
organ-on-a-chip, personalized medicine, precision medicine, microfluidic organ models, patient-derived cells, induced pluripotent stem cell-derived cells, alveolar epithelial cells, patient health data, predictive value, stakeholder collaboration
MeSH terms
Equipment Design, Humans, Tissue Array Analysis, Lab-On-A-Chip Devices, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review